Journal of Animal and Veterinary Advances
Year:
2012
Volume:
11
Issue:
9
Page No.
1512 - 1517
References
Fowler, V.L., N.J. Knowles, D.J. Paton and P.V. Barnett, 2010. Marker vaccine potential of a foot-and-mouth disease virus with a partial VP1 G-H loop deletion. Vaccine, 28: 3428-3434.
CrossRef | Holmgren, J., C. Czerkinsky, K. Eriksson and A. Mharandi, 2003. Mucosal immunisation and adjuvants: A brief overview of recent advances and challenges. Vaccine, 21: S89-S95.
CrossRef | Direct Link | Hu, B., C. Li, H. Lu, Z. Zhu and S. Du et al., 2011. Immune responses to the oral administration of recombinant
Bacillus subtilis expressing multi-epitopes of foot-and-mouth disease virus and a cholera toxin B subunit. J. Virol. Methods, 171: 272-279.
PubMed | Liu, Z.M., H.L. Zhao, C. Xue, B.B. Deng and W. Zhang
et al., 2005. Secretory expression and characterization of a recombinant-deleted variant of human hepatocyte growth factor in
Pichia pastoris. World J. Gastroenterol., 11: 7097-7103.
PubMed | Moraes, M.P., T. de los Santos, M. Koster, T. Turecek, H. Wang, V.G. Andreyev and M.J. Grubman, 2007. Enhanced antiviral activity against foot-and-mouth disease virus by a combination of type I and II porcine interferons. J. Virol., 81: 7124-7135.
CrossRef | PubMed | Shi, X.J., B. Wang, C. Zhang and M. Wang, 2006. Expressions of bovine IFN-gamma and foot-and-mouth disease VP1 antigen in
P. pastoris and their effects on mouse immune response to FMD antigens. Vaccine, 24: 82-89.
PubMed | Sobrino, F., M. Saiz, M.A. Jimenez-Clavero, J.I. Nunez, M.F. Rosas, E. Baranowski and V. Ley, 2001. Foot-and-mouth disease virus: A long known virus, but a current threat. Vet. Res., 32: 1-30.
CrossRef | PubMed | Song, H., Z. Wang, D. Zheng, W. Fang and Y. Li
et al., 2005. A novel mucosal vaccine against foot-and-mouth disease virus induces protection in mice and swine. Biotechnol Lett., 27: 1669-1674.
PubMed | Su, C., X. Duan, X. Wang, C. Wang, R. Cao, B. Zhou and P. Chen, 2007. Heterologous expression of FMDV immunodominant epitopes and HSP70 in
P. pastoris and the subsequent immune response in mice. Vet Microbiol., 124: 256-263.
PubMed | Summerfield, A., L. Guzylack-Pirioua, L. Harwooda and K.C. McCullough, 2009. Innate immune responses against foot-and-mouth disease virus: current understanding and future directions. Vet. Immunol. Immunopathol., 128: 205-210.
CrossRef | Wang, J.H., C.M. Liang, J.M. Peng, J.J. Shieh and M.H. Jong
et al., 2003. Induction of immunity in swine by purified recombinant VP1 of foot-and-mouth disease virus. Vaccine, 21: 3721-3729.
PubMed | Yamamoto, M., J.R. McGhee, Y. Hagiwara, S. Otake and H. Kiyono, 2001. Genetically manipulated bacterial toxin as a new generation mucosal adjuvant. Scand. J. Immunol., 53: 211-217.
PubMed | Zhang, Z.D., G. Hutching, P. Kitching and S. Alexandersen, 2002. The effects of gamma interferon on replication of foot-and-mouth disease virus in persistently infected bovine cells. Arch. Virol., 147: 2157-2167.
PubMed |